New prep for colon screen uses four pills, not liquid laxative

August 31, 2012 by Alan Mozes, Healthday Reporter
New prep for colon screen uses four pills, not liquid laxative
Researchers think the easier regimen will encourage more to get 'virtual colonoscopy'

(HealthDay)—Prepping for a "virtual colonoscopy" at the Mayo Clinic now only involves swallowing four cleansing tablets, rather than the large amounts of liquid laxative typically required, researchers report.

This summer, Mayo embraced the tablet bowel prep as its standard of care for undergoing noninvasive colonography, which relies on a CT scan to generate a 3-D snapshot of the patient's colon and rectum.

The four-tablet prep, which contains the laxative agent bisacodyl, would not sufficiently prepare patients for a standard , which involves the insertion of a into the patient's for a real-time visual inspection of the region.

The screenings are recommended for people over 50 for early detection of colon cancer. The colonography route would suffice for the vast majority of patients, the Mayo team says, raising the prospect that an easier prep experience may encourage more people to undergo .

"About 70 million Americans are eligible for a screening," said Dr. C. Daniel Johnson, chair of the 's department of radiology in Arizona. "But today only about half actually do it. And one of the major obstacles has been the inconvenience of the bowel prep, which requires ingesting about a gallon of liquid the day before the procedure."

When they compared the effect of a tablet prep vs. the full bowel prep in a group of colonography patients, "we really didn't find any discernable difference between the two," he added.

Johnson and his colleagues discussed their analysis of the tablet-prep option last year in the journal Abdominal Imaging.

Colonography is an extremely accurate means of picking up polyps that are either intermediate (6 to 9 millimeters) or large (1 centimeter or more), the researchers say.

However, Dr. David Greenwald, the gastrointestinal fellowship training director at Montefiore Medical Center at the College of Medicine in New York City, pointed out that a is not as good as colonoscopy at spotting smaller polyps, which may be precancerous or cancerous already.

Greenwald, a spokesman for the American Society for Gastrointestinal Endoscopy, also said that a colonoscopy has an advantage over a colonography in that any identified polyp can be removed right then without having to undergo a secondary procedure.

"But having said that, the first goal is to identify people with polyps," he said. "So, any way we can help to get people into screening is welcome."

is really a preventable disease, he added. "Many people believe that the standard prep for these screenings is the hardest part of the procedure and keeps screening rates down, so if bisacodyl tablets can get people into colonography screenings and help to find those polyps, that's a good thing."

Johnson acknowledged, however, that a colonography isn't for everybody.

"About 2 to 5 percent of the population, those who have an inflammatory disease or an inherited disorder with multiple polyps forming at the colon, would be considered high-risk patients, and would need to undergo a colonoscopy," he explained. "And for that the tablets would leave behind fecal debris in the colon that would interfere with the procedure. So they would need a full bowel prep."

Mayo's target population for the tablet prep? "The vast majority of patients over 50 who we would say are at average or intermediate risk for colorectal cancer would be eligible for CT colonography," Johnson added.

"Of course, if we find a polyp during a colonography that patient has to then go on to have a colonoscopy," he said. "But we only find a polyp that needs to be removed about 12 percent of the time. So that means that you have an 88 percent chance of not having to go on to a colonoscopy and undertake the more burdensome prep it involves. And we think those are pretty good odds."

Explore further: Study: Virtual colonoscopy effective screening tool for adults over 65

More information: For more on colorectal cancer, visit the U.S. National Institutes of Health.


Related Stories

Study: Virtual colonoscopy effective screening tool for adults over 65

February 23, 2012
Computed tomography (CT) colonography can be used as a primary screening tool for colorectal cancer in adults over the age of 65, according to a new study published online in the journal Radiology.

Virtual colonoscopy without laxative equals standard in identifying clinically significant polyps

June 14, 2012
Computed tomographic colonography (CTC), also known as virtual colonoscopy, administered without laxatives is as accurate as conventional colonoscopy in detecting clinically significant, potentially cancerous polyps, according ...

CT colonography shown to be comparable to standard colonoscopy

February 23, 2012
Computerized tomographic (CT) colonography (CTC), also known as virtual colonoscopy, is comparable to standard colonoscopy in its ability to accurately detect cancer and precancerous polyps in people ages 65 and older, according ...

Study answers Medicare concerns about paying for CT colonography

July 1, 2012
A new study of 1,400 Medicare-aged patients reinforces CT colonography as a screening tool for colon cancer, adding to the continued debate over Medicare coverage of the procedure.

Recommended for you

Encouraging oxygen's assault on iron may offer new way to kill lung cancer cells

November 22, 2017
Blocking the action of a key protein frees oxygen to damage iron-dependent proteins in lung and breast cancer cells, slowing their growth and making them easier to kill. This is the implication of a study led by researchers ...

One-size treatment for blood cancer probably doesn't fit all, researchers say

November 22, 2017
Though African-American men are three times more likely to be diagnosed with a blood cancer called multiple myeloma, most scientific research on the disease has been based on people of European descent, according to a study ...

Combination immunotherapy targets cancer resistance

November 22, 2017
Cancer immunotherapy drugs have had notable but limited success because in many cases, tumors develop resistance to treatment. But researchers at Yale and Stanford have identified an experimental antibody that overcomes this ...

One in four U.S. seniors with cancer has had it before

November 22, 2017
(HealthDay)—For a quarter of American seniors, a cancer diagnosis signals the return of an old foe, new research shows.

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.